NEWS

  • All
  • Corporate News
  • Media
All
  • All
  • Corporate News
  • Media
Corporate News

Mainz Biomed to Participate in H.C. Wainwright Global Investment Conference and Equity Forum German Spring Conference

Read More
Corporate News

Mainz Biomed to Host Key Opinion Leader Event at DDW 2022

Read More
Corporate News

Mainz Biomed Provides Product Development Update on PancAlert

Read More
Corporate News

Mainz Biomed Appoints Darin Leigh as Chief Commercial Officer

Read More
Corporate News

Mainz Biomed Announces First Quarter 2022 Results

Read More
Corporate News

Mainz Biomed Completes Successful Pre-Submission Process with the U.S. FDA for ColoAlert’s Pivotal Clinical Trial

Read More